ZURICH, Feb 2 (Reuters) - Food giant Nestle NESN.VX said on Wednesday it had acquired CM&D Pharma Ltd., which makes a chewing gum to help people suffering from kidney disease, to build up its newly created health science unit.
UK-based CM&D is a small company specialising in the development of products tailored for patients with kidney disease, inflammatory bowel disease, and colon cancer, Nestle said without disclosing the financial terms of the deal.
“This acquisition is an excellent fit with Nestle Health Sciences strategic goal of being a pioneer in the promising area of science-based nutrition,” said Luis Cantarell, head of the Nestle unit created at the beginning of the year in a statement.
The Vevey-based maker of Nescafe coffee, KitKat chocolate bars and Maggi soup has begun a push into the growth market of foods with health-benefit claims. It plans to invest about 500 million Swiss francs into its new subsidiary over the next decade.[ID:nLDE68N187] (Reporting by Silke Koltrowitz; editing by Alexander Smith)